Background: SARS-CoV-2 (Severe acute respiratory syndrome corona virus 2) seroprevalence studies are being conducted all over the world to identify the level of exposure to the virus, thus giving us a true estimate of the hidden burden of infection in undiagnosed asymptomatic subjects